Outcomes Associated With the Use of Secondary Prevention Medications After Coronary Artery Bypass Graft Surgery

Greater use of indicated secondary prevention medications after coronary artery bypass graft surgery is associated with a lower 2-year rate of death or myocardial infarction. These data underscore the importance of appropriate secondary prevention measures to improve long-term clinical outcomes after coronary artery bypass graft surgery.